Posaconazole for treatment of refractory invasive fungal disease

Mycoses

Volumn 49, Issue SUPPL. 1, 2006, Pages 37-41

  Notheis, G ^a   Tarani, L ^b   Costantino, F ^b   Jansson, A ^a   Rosenecker, J ^a   Friederici, D ^c   Belohradsky, B H ^a   Reinhardt, D ^a   Seger, R ^d   Schweinitz, D V ^a   Wintergerst, Uwe ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Children's Hospital 'La Sapienza'   (Italy)

^c Essex Pharma GmbH   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Aspergillosis; Children; Chronic granulomatous disease; Diabetes mellitus; Immunodeficiency; Mucor mycosis; Posaconazole; Zygomycosis

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; COTRIMOXAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS NIDULANS; BRAIN INFECTION; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MYCOSIS; NASAL BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THORACOTOMY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIDULANS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DRUG RESISTANCE, FUNGAL; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; MALE; MUCORMYCOSIS; RHIZOPUS; SINUSITIS; TREATMENT OUTCOME; TRIAZOLES;

EMERICELLA NIDULANS; MUCOR;

EID: 33748554825     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01301.x     Document Type: Article

References (15)

1. Winkelstein JA, Marino MC, Johnston RB et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155-69.
2. Bhadada S, Bhansali A, Reddy KS et al. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr 2005; 72: 671-4.
3. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-71.
4. Sun QN, Najvar LK, Bocanegra R et al. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002; 46: 2310-2.
5. Gupta AK, Kohli Y, Batra R. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med Mycol 2005; 43: 179-85.
6. Pitisuttithum P, Negroni R, Graybill JR et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005; 56: 745-55.
7. Segal BH, Barnhart LA, Anderson VL et al. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005; 40: 1684-8.
8. Bielorai B, Toren A, Wolach B et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 26: 1025-8.
9. Ott MG, Schmidt M, Schwarzwaelder K et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006; 4: 401-9.
10. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
11. Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 2005; 48: 246-50.
12. Chadli-Chaieb M, Bchir A, Fathallah-Mili A et al. [Mucormycosis in the diabetic patient]. Presse Med 2005; 34: 218-22.
13. Bhansali A, Bhadada S, Sharma A et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004; 80: 670-4.
14. Brugiere O, Dauriat G, Mal H et al. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation 2005; 80: 1361-2.
15. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004; 8: 103-10.